Teprotumumab – July 2026

  • Brand names:
    • Tepezza®
  • Pharmaceutical Company:
    • AMGEN AUSTRALIA PTY LIMITED
  • Condition/Indication: Thyroid eye disease (TED)
  • Meeting Date: July 2026
Public Summary Documents
Last updated
13 November 2026